s6y Citius Pharmaceuticals, Inc. 10-Q

Citius Pharmaceuticals, Inc. 10-Q, filed Feb 13, 2020: IDEA: XBRL DOCUMENT

Going Concern Uncertainty and Management's Plan (Details) - USD ($)
3 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Going Concern Uncertainty and Management's Plan (Textual)    
Cash flows from operations $ (5,114,260) $ (2,158,530)
Working capital deficit $ 794,467